Free Trial

Nexien BioPharma (NXEN) SEC Filings & 10K Form

Nexien BioPharma logo
$0.0057 -0.01 (-47.71%)
As of 01/21/2025 10:04 AM Eastern

Recent Nexien BioPharma SEC Filings

DateFilerForm TypeView
11/18/2024
11:57 AM
Nexien BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2024
2:14 PM
Nexien BioPharma (Filer)
Form NT 10-Q
10/22/2024
2:00 PM
Nexien BioPharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
09/30/2024
5:07 AM
Nexien BioPharma (Filer)
Form NT 10-K
05/28/2024
10:57 AM
Nexien BioPharma (Issuer)
Wasoff Evan L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
10:58 AM
Greenberg Richard S (Reporting)
Nexien BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
5:19 AM
Nexien BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/20/2024
5:19 AM
Nexien BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/14/2024
5:04 AM
Nexien BioPharma (Filer)
Form NT 10-Q
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (OTCMKTS:NXEN) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners